We are live on ! Find out more
US Bancorp

US Bancorp Portfolio holdings

AUM $91.6B
1-Year Est. Return 29.2%
This Fund
S&P 500
This Quarter Est. Return
+2.77%
1 Year Est. Return
+29.2%
3 Year Est. Return
+76.81%
5 Year Est. Return
+86.62%
10 Year Est. Return
+295.59%
AUM
$30B
AUM Growth
+$778M
Cap. Flow
+$100M
Cap. Flow %
0.33%
Top 10 Hldgs %
23.18%
Holding
3,750
New
145
Increased
1,199
Reduced
1,328
Closed
155

Top Sells

Rank Stock Value
1
CAH icon
Cardinal Health
CAH
+$30.2M
2
VAL
Valspar
VAL
+$28.1M
3
MBLY
Mobileye N.V.
MBLY
+$26.8M
4
MMM icon
3M
MMM
+$17.9M
5
PG icon
Procter & Gamble
PG
+$16.1M

Sector Composition

Rank Sector Weight
1 Miscellaneous 29.33%
2 Industrials 12.32%
3 Financials 11.41%
4 Healthcare 10.84%
5 Technology 8.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DJCI
3426
DELISTED
ETRACS Linked to the Bloomberg Commodity Index Total Return due October 31, 2039
DJCI
$2K ﹤0.01%
105
-214
-67% -$3.23K
TRCO
3427
DELISTED
TRIBUNE MEDIA COMPANY CLASS A
TRCO
$2K ﹤0.01%
56
AST
3428
DELISTED
Asterias Biotherapeutics Inc. Series A
AST
$2K ﹤0.01%
687
ABUS icon
3429
Arbutus Biopharma
ABUS
$1.02B
$1K ﹤0.01%
200
AXTI icon
3430
AXT Inc
AXTI
$4.04B
$1K ﹤0.01%
100
BCLI
3431
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$1K ﹤0.01%
18
CENX icon
3432
Century Aluminum
CENX
$4.63B
$1K ﹤0.01%
+70
New +$976
CFA icon
3433
VictoryShares US 500 Volatility Wtd ETF
CFA
$539M
$1K ﹤0.01%
30
CLDX icon
3434
Celldex Therapeutics
CLDX
$3.12B
$1K ﹤0.01%
25
CMCM
3435
Cheetah Mobile
CMCM
$105M
$1K ﹤0.01%
14
CYTK icon
3436
Cytokinetics
CYTK
$10.1B
$1K ﹤0.01%
74
DALN
3437
DELISTED
DallasNews
DALN
$1K ﹤0.01%
40
DMLP icon
3438
Dorchester Minerals
DMLP
$1.43B
$1K ﹤0.01%
100
DRD
3439
DRDGold
DRD
$2.48B
$1K ﹤0.01%
200
FCNCA icon
3440
First Citizens BancShares
FCNCA
$24.9B
$1K ﹤0.01%
4
FLWS icon
3441
1-800-Flowers.com
FLWS
$239M
$1K ﹤0.01%
117
FNDE icon
3442
Schwab Fundamental Emerging Markets Large Company Index ETF
FNDE
$10.6B
$1K ﹤0.01%
22
FNDX icon
3443
Schwab Fundamental US Large Company Index ETF
FNDX
$27.9B
$1K ﹤0.01%
81
-9,000
-99% -$101K
FPI
3444
Farmland Partners
FPI
$465M
$1K ﹤0.01%
100
FRME icon
3445
First Merchants
FRME
$2.64B
$1K ﹤0.01%
36
FTK icon
3446
Flotek Industries
FTK
$853M
$1K ﹤0.01%
16
-29
-64% -$1.82K
FXZ icon
3447
First Trust Materials AlphaDEX Fund
FXZ
$404M
$1K ﹤0.01%
30
GLRE icon
3448
Greenlight Captial
GLRE
$503M
$1K ﹤0.01%
40
-113
-74% -$2.36K
GRX
3449
Gabelli Healthcare & Wellness Trust
GRX
$148M
$1K ﹤0.01%
112
GSG icon
3450
iShares S&P GSCI Commodity-Indexed Trust
GSG
$1.01B
$1K ﹤0.01%
119

Similar funds

US Bancorp's Q2 2017 Portfolio in Review

As of Q2 2017, US Bancorp held 3,750 positions worth $30B, up 2.7% from $29.2B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

US Bancorp's Q2 2017 filing shows 145 new, 1,199 increased, 1,328 reduced and 155 closed positions. Its largest new stake was DXC Technology: 95,517 shares worth $6.34M. The largest sale was Cardinal Health, an estimated $30.2M.

By sector, the portfolio is most concentrated in Miscellaneous at 29% of assets, up from 28% a quarter earlier, followed by Industrials and Financials.

  • US Bancorp's largest Q2 2017 buy was DXC Technology: 95,517 shares worth $6.34M.
  • US Bancorp added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $33.8M increase.
  • US Bancorp's biggest Q2 2017 reduction was Cardinal Health, cutting an estimated $30.2M.
  • US Bancorp fully exited Valspar in Q2 2017, selling an estimated $28.1M.
  • US Bancorp's ten largest holdings make up 23% of its $30B portfolio in Q2 2017.
  • US Bancorp opened 145 new positions and closed 155 in Q2 2017.
  • US Bancorp's portfolio value rose 2.7% quarter-over-quarter to $30B.

Based on US Bancorp's 13F filing for Q2 2017, filed 20 Jul 2017.